Abstract:
A robot includes a link portion including a plurality of link members and a drive portion to rotate the link members, and axes of rotation of the drive portion extending from end portions of the link members is positioned at an identical point.
Abstract:
Provided are a robot for managing a structure, and a method of controlling the robot. The robot for maintaining and repairing the structure measures a luminance value by capturing an image of the structure, or measures depth information of the structure by using a laser sensor or stereo vision, determines a protruding portion or depressed portion of the structure by using the measured luminance value or the measured depth information. Also, the robot removes the determined protruding portion and fills the determined depressed portion by using a combination hardener. Accordingly, protrusion, depression, and crack of a wall caused by deterioration or poor construction of the structure may be automatically found and repaired so as to efficiently manage the structure.
Abstract:
A stereo type distance recognition apparatus and method are provided. The stereo type distance recognition apparatus may include a plurality of sensors to generate a plurality of infrared (IR) signals, a communication unit to transmit the generated IR signals to an object, and a processor to compute a distance with the object, based on signals reflected from the object by the IR signals.
Abstract:
Disclosed is a PLGA (poly(D,L-lactide-co-glycolide)) cell scaffold. The cell scaffold is based on a PLGA scaffold, which is an FDA-approved material with no cytotoxicity, and overcomes the problem with conventional PLGA scaffolds of poor cell adhesion.
Abstract:
The present invention relates to an organic light-emitting short-term visual stimulation platform for brain function control. The visual stimulation platform, according to an aspect of the present invention, comprises: an OLED module; a control unit which controls an operation of the OLED module; and a power supply unit which supplies operating power to the OLED module and the control unit, wherein the visual stimulation platform is configured as a wearable device to project light generated from the OLED module to the eyes of a user under the control by the control unit, and the control unit may include a time setting unit, a brightness setting unit, a frequency setting unit, and a duty ratio setting unit for light generation of the OLED module.
Abstract:
A drug delivery device and a method for manufacturing the same, and more specifically, a drug delivery device that can deliver a drug to a biological tissue while minimizing damage thereto and can come into close contact with the biological tissue to be able to measure an electrical signal of or apply electrical stimulation to the biological tissue and a method for manufacturing the drug delivery device are proposed. The drug delivery device includes a substrate unit that is inserted into a human body and has a porous insertion portion having one or more discharge voids. The insertion portion is provided to be deformable to match a shape of a biological tissue while expanding and contracting as a drug is injected into and discharged from an inside of the injection portion.
Abstract:
Provided are an odorant receptor marker of microglia and a use thereof, and according to the odorant receptor marker of microglia and a use thereof according to one aspect, microglia may be detected by measuring an activity or expression level of a protein of an odorant receptor (OR) Olfr110 or Olfr111, and OR ligands of microglia may be selected using them, and an inhibitor or activator against the interaction between the OR and 2-pentylfuran is effectively used in treatment of a neuroinflammatory disease or meningitis.
Abstract:
Disclosed herein are a pharmaceutical composition comprising an inhibitor of Olfr164 for the prevention or treatment of sepsis, a method for the prevention or treatment of sepsis, a use of Olfr164 as a marker for selecting sepsis therapeutic agents, a screening method for sepsis therapeutics using same, and a transgenic animal in which Olfr164 is knocked out. The composition comprising Olfr164 inhibitor can effectively prevent or treat sepsis. Additionally, sepsis therapeutics can be effectively screened by comparing the expression level or activity of Olfr164 before and after administering the candidate substance.
Abstract:
Disclosed are a bladder monitoring method and apparatus based on a multi-channel strain bladder sensor, and a multi-channel strain bladder sensor verification method and apparatus. The multi-channel strain bladder sensor verification method according to an embodiment of the present disclosure may comprise the steps of: controlling expansion and contraction of a measurement object acting as a bladder; acquiring a sensing value from each channel of a bladder sensor attached to the measurement object, according to the control of expansion and contraction of the measurement object; tracking the volume change and expansion direction of the measurement object by analyzing data regarding the change in the sensing value from each channel of the bladder sensor; and verifying the bladder sensor on the basis of whether the volume change and expansion direction of the measurement object are included within the standard range corresponding to the control of expansion and contraction of the measurement object.
Abstract:
The present invention pertains to: a switching device based on spin-orbit torque; and a method for manufacturing same. A switching device based on spin-orbit torque according to an embodiment comprises: a heavy metal input terminal extending in a first direction; and an information terminal extending in a second direction perpendicular to the first direction on the heavy metal input terminal and having a ferromagnetic layer, wherein the information terminal includes a first region adjacent to the heavy metal input terminal and a second region not adjacent to the heavy metal input terminal, and magnetization reversal of the ferromagnetic layer can be controlled on the basis of a non-uniform spin Hall effect (SHE) caused by the first region and the second region.